Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 3R37CA269649-03S1 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Stolley, Melinda R

Medical College Of Wisconsin
United States

Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors 3R01CA229546-05S1
Stolley, Melinda R

Medical College Of Wisconsin
United States

Every Day Counts: A lifestyle program for women metastatic breast cancer 5R01CA258759-04 PAR-18-893 (R01 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 5R21CA279916-02 Matthew Young, Ph.D.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 5UG1CA189821-11 Vanessa A. White, M.P.H.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 5R01CA278816-02 Matthew Young, Ph.D.
Sun, Ju

University Of Minnesota
United States

SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data 5R01CA287413-02
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-03 Guillermo Marquez, Ph.D.
Svatek, Robert Scott

University Of Texas Hlth Science Center
United States

eRapa for bladder cancer prevention 5R01CA252057-05 PAR-19-183 (R01 Clinical Trial Optional) Howard L. Parnes, M.D.